Cyber Security is no longer an IT function. It is a quality and regulatory obligation.

Why CyberGXP Exists

Generic cyber security services are not designed for regulated environments.

 Pharmaceutical organisations operate under:

  • GxP expectations

  • Continuous inspection readiness

  • Strict data integrity principles

  • Complex third-party ecosystems

  • Cross-border patient and trial data requirements

CyberGXP was created to address one core risk:
Loss of regulatory confidence due to compromised data integrity.

What We Do
A digital illustration of a circuit board with a glowing neon padlock symbol in the center, representing cybersecurity or data protection.
A doctor and a patient review an electrocardiogram (ECG) on a clipboard during a consultation in a medical office.
A scientist in a laboratory wearing protective gear, using a microscope and analyzing scientific data on a computer screen.
Two businessmen in suits discussing standing over a table with laptops and papers in a modern office with glass walls.

Our Difference

Most cyber security firms sell tools.

Most MSPs sell uptime.

CyberGXP protects regulatory outcomes.

Our cyber security approach is designed to support regulated clinical and manufacturing environments by protecting critical systems, maintaining compliance, and reducing risk across the product lifecycle. We focus on:

  • Trial continuity

  • Inspection readiness

  • Data integrity assurance

  • Regulatory confidence

Because the financial and regulatory impact of delayed approval outweighs the cost of a properly executed cyber security programme.

Cyber Security designed for regulated pharmaceutical environments.

Because your approval depends on it.

Speak to a Specialist →